Fig. 1From: Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in USMarkov model. States include controlled, partially controlled, uncontrolled, non-severe exacerbation, severe exacerbation without hospitalization, and hospitalizationBack to article page